# John Banta

> John Banta is a Series A investor at The Blue Venture Fund backing Health Care and Risk Management. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [The Blue Venture Fund](https://shizune.co/investors/profile/bluecross-blueshield-venture-partners)
- Location: Chicago, United States
- Total investments: 5
- Last investment: Jul 2018
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/johnedwardsbanta/

John Banta is a Series A investor at The Blue Venture Fund in Chicago focused on Health Care and Risk Management. John Banta is the Vice President of Investments at BlueCross BlueShield Venture Partners. He is also the President and Managing Director at The Blue Venture Fund. He attended The University of Chicago Booth School of Business and the University of Illinois Urbana-Champaign.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 20% |
| Risk Management | 1 | 20% |
| Machine Learning | 1 | 20% |
| Predictive Analytics | 1 | 20% |
| Artificial Intelligence | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 20% |
| Series B | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lumiata | Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico. | $11M | Series B | Jul 10, 2018 |  |
| Lumiata | Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico. | $11M | Series B | Jul 10, 2018 |  |
| Lumiata | Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico. | $10M | Series B | May 26, 2016 |  |
| Lumiata | Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico. | $6M | Series A | Sep 11, 2014 |  |
| Lumiata | Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico. | $6M | Series A | Sep 11, 2014 |  |

5 of 5 investments shown.

## Co-investors
- [Sandbox Industries](https://shizune.co/investors/profile/sandbox-industries) — VC Fund, 5 deals together
- [Intel Capital](https://shizune.co/investors/profile/intel-capital) — VC Fund, 3 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 3 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 2 deals together
- [The Blue Venture Fund](https://shizune.co/investors/profile/bluecross-blueshield-venture-partners) — VC Fund, 2 deals together
- [Leawood Venture Capital](https://shizune.co/investors/profile/leawood-capital) — VC Fund, 2 deals together

## About The Blue Venture Fund

VC Fund · Chicago, United States

The Blue Venture Fund is a strategic investment vehicle that aims to foster innovation within the healthcare system. The Blue Venture Fund invests in emerging healthcare companies that have the potential to improve the quality of care, enhance patient experience, and reduce costs. It seeks to support companies that align with the needs andpriorities of Blue Cross Blue Shield (BCBS) member companies and their policyholders.

1 contacts available at The Blue Venture Fund.

| Name | Title | Profile |
| --- | --- | --- |
| John Banta | Vice President of Investments; President and Managing Director | https://shizune.co/investors/profile/john-banta |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does John Banta invest in?

John Banta invests primarily in Health Care, Risk Management and Machine Learning startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did John Banta last invest?

The most recent investment recorded for John Banta closed in Jul 2018. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co